Serum FABP5 concentration is a potential biomarker for residual risk of atherosclerosis in relation to cholesterol efflux from macrophages.

导出 LinkOut

翻译打印收藏纠错

第一作者： Masato,Furuhashi

第一单位： Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan. furuhasi@sapmed.ac.jp.

作者： Masato,Furuhashi ^[1] ; Masatsune,Ogura ^[2] ; Megumi,Matsumoto ^[3] ; Satoshi,Yuda ^[4] ; Atsuko,Muranaka ^[3] ; Mina,Kawamukai ^[3] ; Akina,Omori ^[3] ; Marenao,Tanaka ^[3] ; Norihito,Moniwa ^[3] ; Hirofumi,Ohnishi ^[3] ; Shigeyuki,Saitoh ^[5] ; Mariko,Harada-Shiba ^[3] ; Kazuaki,Shimamoto ^[6] ; Tetsuji,Miura ^[2]

作者单位： Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan. furuhasi@sapmed.ac.jp. ^[1] Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute, Suita, Japan. ^[2] Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan. ^[3] Devision of Cardiology, Cardiovascular Center, Teine Keijinkai Hospital, Sapporo, Japan. ^[4] Department of Public Health, Sapporo Medical University School of Medicine, Sapporo, Japan. ^[5] Department of Nursing, Division of Medical and Behavioral Subjects, Sapporo Medical University School of Health Sciences, Sapporo, Japan. ^[6] Japan Health Care College, Sapporo, Japan. ^[7]